Inhibrx End Period Cash Flow vs Free Cash Flow Per Share Analysis

INBX Stock  USD 15.26  0.37  2.37%   
Inhibrx financial indicator trend analysis is infinitely more than just investigating Inhibrx recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inhibrx is a good investment. Please check the relationship between Inhibrx End Period Cash Flow and its Free Cash Flow Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

End Period Cash Flow vs Free Cash Flow Per Share

End Period Cash Flow vs Free Cash Flow Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inhibrx End Period Cash Flow account and Free Cash Flow Per Share. At this time, the significance of the direction appears to have pay attention.
The correlation between Inhibrx's End Period Cash Flow and Free Cash Flow Per Share is -0.97. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Free Cash Flow Per Share in the same time period over historical financial statements of Inhibrx, assuming nothing else is changed. The correlation between historical values of Inhibrx's End Period Cash Flow and Free Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Inhibrx are associated (or correlated) with its Free Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Per Share has no effect on the direction of End Period Cash Flow i.e., Inhibrx's End Period Cash Flow and Free Cash Flow Per Share go up and down completely randomly.

Correlation Coefficient

-0.97
Relationship DirectionNegative 
Relationship StrengthSignificant

End Period Cash Flow

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.
Most indicators from Inhibrx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inhibrx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.At this time, Inhibrx's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 210 M in 2024, whereas Tax Provision is likely to drop 2,565 in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses83.7M131.3M219.8M230.8M
Cost Of Revenue2.7M2.8M1.2M1.1M

Inhibrx fundamental ratios Correlations

0.98-0.060.68-0.980.610.330.920.160.930.920.650.64-0.53-0.720.920.720.920.92-0.220.770.75-0.210.970.790.9
0.980.090.64-0.950.730.440.90.350.910.880.650.76-0.42-0.740.90.820.880.9-0.250.740.75-0.310.940.80.86
-0.060.09-0.460.10.140.16-0.160.69-0.13-0.1-0.370.520.830.23-0.150.4-0.12-0.15-0.390.090.09-0.17-0.170.1-0.23
0.680.64-0.46-0.720.650.560.810.140.810.680.980.47-0.71-0.940.810.530.680.81-0.020.430.46-0.480.810.50.84
-0.98-0.950.1-0.72-0.63-0.26-0.97-0.17-0.97-0.97-0.7-0.650.570.76-0.97-0.76-0.97-0.970.26-0.86-0.840.13-0.99-0.87-0.94
0.610.730.140.65-0.630.720.690.680.710.570.760.84-0.3-0.850.70.870.560.7-0.20.420.54-0.650.660.60.66
0.330.440.160.56-0.260.720.340.590.350.150.620.59-0.05-0.670.340.510.150.34-0.07-0.090.05-0.990.330.130.36
0.920.9-0.160.81-0.970.690.340.181.00.970.810.65-0.62-0.851.00.760.971.0-0.360.790.84-0.220.980.860.99
0.160.350.690.14-0.170.680.590.180.210.090.280.840.46-0.380.190.750.070.19-0.120.190.16-0.570.170.210.1
0.930.91-0.130.81-0.970.710.351.00.210.970.810.68-0.6-0.861.00.780.971.0-0.360.80.85-0.230.980.870.99
0.920.88-0.10.68-0.970.570.150.970.090.970.660.59-0.57-0.720.970.711.00.97-0.440.860.9-0.030.960.910.96
0.650.65-0.370.98-0.70.760.620.810.280.810.660.56-0.65-0.980.820.620.670.82-0.080.430.49-0.540.790.530.83
0.640.760.520.47-0.650.840.590.650.840.680.590.560.09-0.680.660.980.580.66-0.30.610.61-0.510.640.660.59
-0.53-0.420.83-0.710.57-0.3-0.05-0.620.46-0.6-0.57-0.650.090.59-0.62-0.08-0.59-0.62-0.08-0.31-0.39-0.02-0.62-0.39-0.67
-0.72-0.740.23-0.940.76-0.85-0.67-0.85-0.38-0.86-0.72-0.98-0.680.59-0.86-0.74-0.72-0.860.16-0.49-0.570.59-0.83-0.62-0.87
0.920.9-0.150.81-0.970.70.341.00.191.00.970.820.66-0.62-0.860.770.971.0-0.370.790.84-0.230.980.860.99
0.720.820.40.53-0.760.870.510.760.750.780.710.620.98-0.08-0.740.770.70.77-0.320.720.74-0.420.740.780.7
0.920.88-0.120.68-0.970.560.150.970.070.971.00.670.58-0.59-0.720.970.70.97-0.430.860.9-0.020.960.90.96
0.920.9-0.150.81-0.970.70.341.00.191.00.970.820.66-0.62-0.861.00.770.97-0.370.790.84-0.230.980.860.99
-0.22-0.25-0.39-0.020.26-0.2-0.07-0.36-0.12-0.36-0.44-0.08-0.3-0.080.16-0.37-0.32-0.43-0.37-0.23-0.470.06-0.24-0.42-0.38
0.770.740.090.43-0.860.42-0.090.790.190.80.860.430.61-0.31-0.490.790.720.860.79-0.230.920.210.80.920.74
0.750.750.090.46-0.840.540.050.840.160.850.90.490.61-0.39-0.570.840.740.90.84-0.470.920.060.790.990.82
-0.21-0.31-0.17-0.480.13-0.65-0.99-0.22-0.57-0.23-0.03-0.54-0.51-0.020.59-0.23-0.42-0.02-0.230.060.210.06-0.2-0.02-0.25
0.970.94-0.170.81-0.990.660.330.980.170.980.960.790.64-0.62-0.830.980.740.960.98-0.240.80.79-0.20.820.97
0.790.80.10.5-0.870.60.130.860.210.870.910.530.66-0.39-0.620.860.780.90.86-0.420.920.99-0.020.820.83
0.90.86-0.230.84-0.940.660.360.990.10.990.960.830.59-0.67-0.870.990.70.960.99-0.380.740.82-0.250.970.83
Click cells to compare fundamentals

Inhibrx Account Relationship Matchups

Inhibrx fundamental ratios Accounts

201920202021202220232024 (projected)
Other Current Liab4.8M13.4M9.6M17.2M43.9M46.1M
Total Current Liabilities20.6M31.4M22.5M27.6M56.3M59.1M
Other Liab363K2.9M917K110K126.5K120.2K
Net Tangible Assets(93.6M)75.5M52.4M58.1M66.8M70.1M
Retained Earnings(69.3M)(145.4M)(227.1M)(372.4M)(613.7M)(583.0M)
Accounts Payable3.1M13.5M9.1M8.3M8.3M6.8M
Other Current Assets376K132.2M7.8M6.6M28.2M24.3M
Total Current Assets15.6M132.2M139.1M280.5M295.4M310.1M
Property Plant Equipment10.7M11.3M9.5M2.5M2.9M2.7M
Total Assets26.5M143.7M150.5M290.9M307.9M323.3M
Short Long Term Debt Total41.7M37.5M72.1M203.9M210.1M220.6M
Total Stockholder Equity(93.6M)75.5M52.4M58.1M43.5M45.7M
Property Plant And Equipment Net10.7M11.3M9.5M7.2M9.4M8.2M
Current Deferred Revenue7.9M3.1M2.0M166K149.4K141.9K
Net Debt30.2M(91.2M)(60.8M)(71.8M)(67.8M)(64.4M)
Cash11.5M128.7M131.3M273.9M277.9M291.8M
Non Current Assets Total10.9M11.6M11.3M10.4M12.5M9.9M
Long Term Debt30.4M29.2M70.5M202.1M207.0M217.3M
Cash And Short Term Investments11.5M128.7M131.3M273.9M277.9M291.8M
Net Receivables438K615K878K257K778K497.4K
Common Stock Shares Outstanding36.6M25.3M38.0M40.1M47.1M38.2M
Liabilities And Stockholders Equity26.5M143.7M150.5M290.9M307.9M323.3M
Non Current Liabilities Total99.5M36.9M75.6M205.2M208.1M111.2M
Capital Lease Obligations7.8M8.2M6.7M5.0M3.2M4.9M
Inventory3.2M(129.3M)(878K)(257K)(11.6M)(12.2M)
Other Stockholder Equity(24.3M)220.8M279.5M430.4M657.2M690.1M
Total Liab120.1M68.3M98.1M232.8M264.4M140.0M
Net Invested Capital(59.6M)104.7M70.5M260.1M250.5M263.0M
Property Plant And Equipment Gross10.7M11.3M3.2M2.5M16.1M16.9M
Net Working Capital(5.0M)100.8M116.7M252.9M239.0M251.0M
Short Term Debt4.7M1.5M1.7M1.9M4.1M2.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.